Peculiarities of BRCA1/2 testing in patients with advanced HER2-negative breast cancer in the Russian Federation (results of a survey of Russian oncologists)

Автор: Frolova Mona A., Stenina Marina B.

Журнал: Злокачественные опухоли @malignanttumors

Рубрика: Вопросы онкохирургии

Статья в выпуске: 2 т.11, 2021 года.

Бесплатный доступ

Hereditary BRCA1 / 2 mutations affect the strategy of surgical treatment in early cancer and systemic treatment in advanced HER2-negative breast cancer. The article presents the results of a survey of Russian oncologists on various aspects of genetic testing for hereditary BRCA1 / 2 mutations in real-world clinical practice. Indications for testing, testing methods, and funding sources were discussed.

Breast cancer, hereditary brca1/ 2 mutations, genetic testing

Короткий адрес: https://sciup.org/140290742

IDR: 140290742   |   DOI: 10.18027/2224-5057-2021-11-2-38-44

Статья научная